Bruno Villetelle's guest appearances

Bruno Villetelle

StartUp Health NOW Podcast

StartUp Health NOW!

Real World Talk with COTA

Anne Ornish

Steve Case

Sanjay Gupta

Robin Berzin

Andreessen Horowitz

Dean Ornish

Safi Bahcall

Marty Makary

Jeff Allen

Alan Curtis

Susan Schneider

Karen Martel

Andreas Weigend

Esther Dyson

Vinod Khosla

OwlTail

In this episode of Real World Talk, host Emily Di Capua talks to Bruno Villetelle, Global Head of Data and Digital for pharmaceutical company Novartis. They discuss the ways real world data is being used to innovate drug development and delivery so that patients can benefit from new discoveries sooner. For example, real world data is especially valuable in clinical trials with small numbers of participants — something increasingly seen in cancer studies. “While efficacy and safety data collected through randomized clinical trials remain the gold standard, real world data can complement typical development programs by informing the selection of endpoints, the design and recruitment of studies — which can potentially accelerate timelines, reduce clinical trial costs and increase the probability of success,” Villetelle says. Since Di Capua and Villetelle are both involved in COTA and Novartis’s respective diversity initiatives, they talk about the ways a diverse staff benefits companies. They also discuss Novartis’s advances with decentralized trials and how COVID-19 has clarified the need for a modernized long distance approach.

In this episode of Real World Talk, host Emily Di Capua talks to Bruno Villetelle, Global Head of Data and Digital for pharmaceutical company Novartis. They discuss the ways real world data is being used to innovate drug development and delivery so that patients can benefit from new discoveries sooner. For example, real world data is especially valuable in clinical trials with small numbers of participants — something increasingly seen in cancer studies. “While efficacy and safety data collected through randomized clinical trials remain the gold standard, real world data can complement typical development programs by informing the selection of endpoints, the design and recruitment of studies — which can potentially accelerate timelines, reduce clinical trial costs and increase the probability of success,” Villetelle says. Since Di Capua and Villetelle are both involved in COTA and Novartis’s respective diversity initiatives, they talk about the ways a diverse staff benefits companies. They also discuss Novartis’s advances with decentralized trials and how COVID-19 has clarified the need for a modernized long distance approach.

The Role of Real World Data in Bringing Medication to Market and Beyond with Bruno Villetelle

Nicole Mowad-Nassar

Takeda Pharma

Bruno Villetelle, Chief Digital Officer, and Nicole Mowad-Nassar, Vice President of Marketing at Takeda Pharmaceutical, discuss their embarkation on a digital transformation journey; how commercial innovation is bridging the gap between industry, providers, academia and patients to coordinate care; and how large companies evolve as a result of the wave of innovation that's coming into the market.GUEST: Bruno Villetelle and Nicole Mowad-Nassar, Takeda PharmaceuticalHOST: Unity Stoakes, StartUp HealthLOCATION: Wearable Tech + Digital Health Conference, San Francisco, CAIN THIS EPISODE:Lessons Learned by Large Companies Working With Small Emerging StartupsCollaborating With Takeda: Advice to the StartupTakeda in the Future(Access the full transcript here: https://medium.com/p/25d841b9e9fe)

Bruno Villetelle, Chief Digital Officer, and Nicole Mowad-Nassar, Vice President of Marketing at Takeda Pharmaceutical, discuss their embarkation on a digital transformation journey; how commercial innovation is bridging the gap between industry, providers, academia and patients to coordinate care; and how large companies evolve as a result of the wave of innovation that's coming into the market. GUEST: Bruno Villetelle and Nicole Mowad-Nassar, Takeda Pharmaceutical HOST: Unity Stoakes, StartUp Health LOCATION: Wearable Tech + Digital Health Conference, San Francisco, CA IN THIS EPISODE: Lessons Learned by Large Companies Working With Small Emerging Startups Collaborating With Takeda: Advice to the Startup Takeda in the Future (Access the full transcript here: <a href="https://medium.com/p/25d841b9e9fe" rel="nofollow" target="_blank">https://medium.com/p/25d841b9e9fe</a>)

#86: Pharma’s Digital Transformation –  Bruno Villetelle & Nicole Mowad-Nassar, Takeda Pharma